A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
It is thought that treating multiple sclerosis with Novantrone for a short period of time
prior to treatment with Copaxone may enhance the onset effect of Copaxone.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries